Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Wenxia Hu, Bin Li, Nan Geng, Xin He, Hui Ge, Ping Wang & Cuimin Ding. (2021) Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study. International Journal of General Medicine 14, pages 2703-2714.
Read now
Read now
Vera Jokic, Katarina Savic-Vujovic, Jelena Spasic, Nemanja Stanic, Mladen Marinkovic, Davorin Radosavljevic & Milena Cavic. (2021) Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity. Expert Review of Anticancer Therapy 21:6, pages 673-679.
Read now
Read now
Articles from other publishers (18)
Jennifer Cao, Lyndah Chow & Steven Dow. (2023) Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment. Frontiers in Oncology 13.
Crossref
Crossref
Ni Putu Ayu Widiasari, Ida Bagus Ngurah Rai, Ida Ayu Jasminarti Dwi Kusumawardani, I Gede Ketut Sajinadiyasa, Ni Wayan Candrawati & Ni Luh Putu Eka Arisanti. (2023) Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia. Romanian Journal of Internal Medicine 61:1, pages 63-71.
Crossref
Crossref
Takayuki Takeda, Tadaaki Yamada, Keiko Tanimura, Takayuki Nakano, Masaki Ishida, Yusuke Tachibana, Shinsuke Shiotsu, Shigeto Horiuchi, Makoto Hibino, Asuka Okada, Yusuke Chihara & Koichi Takayama. (2021) Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib. Diagnostics 11:12, pages 2170.
Crossref
Crossref
Sze Wah Samuel Chan, Elliot Smith, Reenika Aggarwal, Karmugi Balaratnam, RuiQi Chen, Katrina Hueniken, Rouhi Fazelzad, Jessica Weiss, Shirley Jiang, Frances A. Shepherd, Penelope A. Bradbury, Adrian G. Sacher, Natasha B. Leighl, Wei Xu, M. Catherine Brown, Lawson Eng & Geoffrey Liu. (2021) Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis. Clinical Lung Cancer 22:5, pages 390-407.
Crossref
Crossref
Hou-Qun Ying, Yu-Cui Liao, Yan-Ran Luo, Gang Xiong, Ying Huang, Ruo-Wei Nie, Cui-Fen Xiong & Xue-Xin Cheng. (2021) Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC. Pharmacological Research 170, pages 105734.
Crossref
Crossref
M Harazim & J Chvojka. (2021) What the blood count hides. Anesteziologie a intenzivní medicína 32:2, pages 109-110.
Crossref
Crossref
Nicole K. Yun, Sherin J. Rouhani, Christine M. Bestvina, Ethan M. Ritz, Brendan A. Gilmore, Imad Tarhoni, Jeffrey A. Borgia, Marta Batus, Philip D. Bonomi & Mary Jo Fidler. (2021) Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers 13:6, pages 1426.
Crossref
Crossref
Mingbo Tang, Xinliang Gao, He Sun, Suyan Tian, Junxue Dong, Zhao Liu & Wei Liu. (2021) Neutrophil-Lymphocyte Ratio as a Prognostic Parameter in NSCLC Patients Receiving EGFR-TKIs: A Systematic Review and Meta-Analysis. Journal of Oncology 2021, pages 1-7.
Crossref
Crossref
Xueqi Xie, Xiaolin Li, Wenjie Tang, Jinlong Chen, Peng Xie & Minghuan Li. (2021) Prognostic value of the neutrophil-to-lymphocyte ratio and primary tumor location in epidermal growth factor receptor-mutated metastatic non-small cell lung cancer. Journal of Cancer Research and Therapeutics 17:7, pages 1618.
Crossref
Crossref
Youwei Pu, Zijing Liu, Cheng Zhong, Xuyu Zhang & Yixi Bao. (2020) Immunomodulatory effects of a polysaccharide from Solanum nigrum Linne through TLR4-MyD88 signaling pathway. International Immunopharmacology 88, pages 106973.
Crossref
Crossref
Taihei Ono, Satoshi Igawa, Shintaro Kurahayashi, Yuriko Okuma, Ai Sugimoto, Seiichiro Kusuhara, Takahiro Ozawa, Tomoya Fukui, Jiichiro Sasaki, Hisashi Mitsufuji, Masanori Yokoba, Masaru Kubota, Masato Katagiri & Katsuhiko Naoki. (2020) Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors. Investigational New Drugs 38:3, pages 885-893.
Crossref
Crossref
Yaning Yang, Haiyan Xu, Guangjian Yang, Lu Yang, Junling Li & Yan Wang. (2019) The value of blood biomarkers of progression and prognosis in ALK‐positive patients with non–small cell lung cancer treated with crizotinib. Asia-Pacific Journal of Clinical Oncology 16:1, pages 63-69.
Crossref
Crossref
Eda G. Ramirez-Valles, Alicia Rodríguez-Pulido, Marcelo Barraza-Salas, Isaac Martínez-Velis, Iván Meneses-Morales, Víctor M. Ayala-García & Carlos A. Alba-Fierro. (2020) A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development. Technology in Cancer Research & Treatment 19, pages 153303382095703.
Crossref
Crossref
Chi-Cheng Li, Chih-Bin Lin, Sung-Chao Chu, Wei-Han Huang, Jen-Jyh Lee, Gee-Gwo Yang, Tso-Fu Wang & Yi-Feng Wu. (2020) Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma. Medicine 99:29, pages e21275.
Crossref
Crossref
Jun Gong, Hui Jiang, Chang Shu, Mei-qin Hu, Yan Huang, Qin Liu & Rong-feng Li. (2019) Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis. Journal of Ovarian Research 12:1.
Crossref
Crossref
Kun Huang, Erqiang Hu, Wan Li, Junjie Lv, Yuehan He, Gui Deng, Jinling Xiao, Chengcheng Yang, Xinyu Zhao, Lina Chen & Xinyan Wang. (2019) Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population. BMC Medical Genetics 20:1.
Crossref
Crossref
Yi Fang, Yue Yang, Min Chen, Peijie He, Lei Cheng, Jian Chen & Haitao Wu. (2019) Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia. European Archives of Oto-Rhino-Laryngology 276:10, pages 2857-2864.
Crossref
Crossref
Rui-Xiang Cen & Yu-Gang Li. (2019) Platelet-to-lymphocyte ratio as a potential prognostic factor in nasopharyngeal carcinoma. Medicine 98:38, pages e17176.
Crossref
Crossref